Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols
Danijel Galun
World Journal of Hepatology (2015) Vol. 7, Iss. 20, pp. 2274-2274
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma
Joseph R. Kallini, Ahmed Gabr, Riad Salem, et al.
Advances in Therapy (2016) Vol. 33, Iss. 5, pp. 699-714
Open Access | Times Cited: 147
MicroRNA-125b reverses oxaliplatin resistance in hepatocellular carcinoma by negatively regulating EVA1A mediated autophagy
Weiwei Ren, Dandan Li, Xiaolan Chen, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 5
Open Access | Times Cited: 64
Targeted Therapy and Personalized Medicine
Rida Fatima Saeed, Uzma Azeem Awan, Sidra Saeed, et al.
Cancer treatment and research (2023), pp. 177-205
Closed Access | Times Cited: 22
Targeted therapy and personalized medicine in hepatocellular carcinoma: drug resistance, mechanisms, and treatment strategies
D Galun, Tatjana Srdić‐Rajić, Aleksandar Bogdanović, et al.
Journal of Hepatocellular Carcinoma (2017) Vol. Volume 4, pp. 93-103
Open Access | Times Cited: 56
Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres
Eric A. Wang, Jeff Stein, Ross J. Bellavia, et al.
International Journal of Clinical Practice (2017) Vol. 71, Iss. 11, pp. e12972-e12972
Open Access | Times Cited: 50
MicroRNAs alteration as early biomarkers for cancer and neurodegenerative diseases: New challenges in pesticides exposure
Chiara Costa, Michele Teodoro, Carmela Alessandra Rugolo, et al.
Toxicology Reports (2020) Vol. 7, pp. 759-767
Open Access | Times Cited: 50
MRI Assessment of Hepatocellular Carcinoma after Local-Regional Therapy: A Comprehensive Review
Mishal Mendiratta‐Lala, William R. Masch, Kimberly L. Shampain, et al.
Radiology Imaging Cancer (2020) Vol. 2, Iss. 1, pp. e190024-e190024
Open Access | Times Cited: 44
miR-615-5p prevents proliferation and migration through negatively regulating serine hydromethyltransferase 2 (SHMT2) in hepatocellular carcinoma
Xiaoyu Wu, Liang Deng, Decai Tang, et al.
Tumor Biology (2015) Vol. 37, Iss. 5, pp. 6813-6821
Closed Access | Times Cited: 40
Hepatocellular Carcinoma: Past and Future of Molecular Target Therapy
Khanh Nguyen, Kerri Jack, Weijing Sun
Diseases (2015) Vol. 4, Iss. 1, pp. 1-1
Open Access | Times Cited: 35
Longitudinal study of factors associated with the anti-cancer efficacy and liver function in HCC patients treated with TACE in combination with percutaneous ablation
Hongliang Ren, Jian Chen, Zhiqun Wu, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative-intent surgery for hepatocellular carcinoma: experience from a developing country
Danijel Galun, Aleksandar Bogdanović, Jelena Djokić Kovač, et al.
Cancer Management and Research (2018) Vol. Volume 10, pp. 977-988
Open Access | Times Cited: 30
Effect of surgical margin in R0 hepatectomy on recurrence-free survival of patients with solitary hepatocellular carcinomas without macroscopic vascular invasion
Sheng Dong, Zusen Wang, Liqun Wu, et al.
Medicine (2016) Vol. 95, Iss. 44, pp. e5251-e5251
Open Access | Times Cited: 25
Genetic biomarkers for hepatocellular cancer risk in a caucasian population
Elena De Mattia, Erika Cecchin, Jerry Polesel, et al.
World Journal of Gastroenterology (2017) Vol. 23, Iss. 36, pp. 6674-6684
Open Access | Times Cited: 25
High expression of FOXO3 is associated with poor prognosis in patients with hepatocellular carcinoma
Shushu Song, Jia‐Fu Ying, You‐Ni Zhang, et al.
Oncology Letters (2020)
Open Access | Times Cited: 23
Liver resection versus transarterial chemoembolization for huge hepatocellular carcinoma: a propensity score matched analysis
Aleksandar Bogdanović, Predrag Bulajić, Dragan Mašulović, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 19
Hepatocellular carcinoma Liver Imaging Reporting and Data Systems treatment response assessment: Lessons learned and future directions
Anum Aslam, Richard Kinh Gian, Avinash Kambadakone, et al.
World Journal of Hepatology (2020) Vol. 12, Iss. 10, pp. 738-753
Open Access | Times Cited: 19
Human nuclear receptors (NRs) genes have prognostic significance in hepatocellular carcinoma patients
Guangtao Sun, Sun Kejian, Chao Shen
World Journal of Surgical Oncology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 16
UGT1A polymorphisms as genetic biomarkers for hepatocellular carcinoma risk in Caucasian population
Elena De Mattia, Erika Cecchin, Jerry Polesel, et al.
Liver International (2017) Vol. 37, Iss. 9, pp. 1345-1353
Closed Access | Times Cited: 21
Piplartine suppresses proliferation and invasion of hepatocellular carcinoma by LINC01391-modulated Wnt/β-catenin pathway inactivation through ICAT
Xiaoxi Fan, Jingjing Song, Zhongwei Zhao, et al.
Cancer Letters (2019) Vol. 460, pp. 119-127
Closed Access | Times Cited: 18
Immunotherapy based on dendritic cells pulsed with CTPFoxM1 fusion protein protects against the development of hepatocellular carcinoma
Huiting Su, Bing Li, Lan Zheng, et al.
Oncotarget (2016) Vol. 7, Iss. 30, pp. 48401-48411
Open Access | Times Cited: 17
Angiosomal radiopathologic analysis of transarterial radioembolization for the treatment of hepatocellular carcinoma
Altan Ahmed, Naziya Samreen, Joseph R. Grajo, et al.
Abdominal Radiology (2017) Vol. 43, Iss. 7, pp. 1825-1836
Closed Access | Times Cited: 16
Management of Non-tumoral Portal Vein Thrombosis in Patients with Cirrhosis
Jonathan G. Stine, Patrick G. Northup
Digestive Diseases and Sciences (2018) Vol. 64, Iss. 3, pp. 619-626
Closed Access | Times Cited: 16
RETRACTED: Long noncoding RNA LBX2-AS1 drives the progression of hepatocellular carcinoma by sponging microRNA-384 and thereby positively regulating IRS1 expression
Yu Wang, Shihua Zhao, Xu Zhang, et al.
Pathology - Research and Practice (2020) Vol. 216, Iss. 4, pp. 152903-152903
Closed Access | Times Cited: 13
EVA1A Plays an Important Role by Regulating Autophagy in Physiological and Pathological Processes
Shizhen Zhao, Honggang Wang
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6181-6181
Open Access | Times Cited: 12
Assessment of HCC response to Yttrium-90 radioembolization with gadoxetate disodium MRI: correlation with histopathology
Naïk Vietti Violi, Jeffrey Gnerre, Amy Law, et al.
European Radiology (2022) Vol. 32, Iss. 9, pp. 6493-6503
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top